Supporting our global approach to clinical development and market supply, we recently completed the build of a 29,000-square foot cGMP manufacturing facility located in London. The facility was designed to meet multiple regulatory standards, including the Medicines and Health Products Regulatory Agency (MHRA), in the UK, European Medicine Agency (EMA) and U.S. Food and Drug Administration (FDA) standards.

Our manufacturing team consists of more than 30 highly trained multidisciplinary staff with backgrounds in manufacturing, managing and delivering gene therapy products.